Luke Cunningham is a Cardiology physician affiliated with INTEGRIS Baptist Medical Center. OpenAlex indexes 43 publications with 378 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 NW Expressway Ste 200
Oklahoma City, OK 73112
Telephone
405-713-9900Provider last certified this registry record 2 Sept 2025.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202524 payments$11,803openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- Kestra Medical Technology Services, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63%Beta blocker13.3%Metoprolol Succinate53%Carvedilol47%Part D≥88 patientsAldosterone antagonist (MRA)9.5%Spironolactone85%Eplerenone15%Part D≥83 patients+ 14 more classes in this area
Metabolism & gastrointestinal
18.6%SGLT2 inhibitor9.9%Farxiga63%Jardiance33%Dapagliflozin4%Part D<11 patientsPotassium supplement5.1%Potassium Chloride100%Part D≥64 patients+ 3 more classes in this area
Blood & clotting
11.7%Vitamin K antagonist5.4%Warfarin Sodium100%Part D≥58 patientsFactor Xa inhibitor3.9%Eliquis84%Xarelto16%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Extracorporeal membrane oxygenation for acute decompensated heart failure: Encouraging long term outcomes
The International Journal of Artificial Organs
2026 - Epicardial ventricular tachycardia ablation with a pentaspline catheter during left ventricular assist device placement
Journal of Interventional Cardiac Electrophysiology
2025 - Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
George Chrysant, MD
INTEGRIS Baptist Medical Center
Harlan Wright, MD
INTEGRIS Baptist Medical Center
Marshall Bell, MD
INTEGRIS Baptist Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”